ArticleCellular and molecular life sciences : CMLS2024
The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer.
Natalia Hermán-Sánchez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it